Tetradecanoylphorbol Acetate
"Tetradecanoylphorbol Acetate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA.
| Descriptor ID |
D013755
|
| MeSH Number(s) |
D02.455.849.291.500.510.850
|
| Concept/Terms |
Tetradecanoylphorbol Acetate- Tetradecanoylphorbol Acetate
- Acetate, Tetradecanoylphorbol
- 12-O-Tetradecanoyl Phorbol 13-Acetate
- 12 O Tetradecanoyl Phorbol 13 Acetate
- 13-Acetate, 12-O-Tetradecanoyl Phorbol
- Phorbol 13-Acetate, 12-O-Tetradecanoyl
- Phorbol Myristate Acetate
- Acetate, Phorbol Myristate
- Myristate Acetate, Phorbol
- 12-Myristoyl-13-acetylphorbol
- 12 Myristoyl 13 acetylphorbol
|
Below are MeSH descriptors whose meaning is more general than "Tetradecanoylphorbol Acetate".
Below are MeSH descriptors whose meaning is more specific than "Tetradecanoylphorbol Acetate".
This graph shows the total number of publications written about "Tetradecanoylphorbol Acetate" by people in this website by year, and whether "Tetradecanoylphorbol Acetate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 4 | 5 |
| 2005 | 0 | 4 | 4 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tetradecanoylphorbol Acetate" by people in Profiles.
-
Zhang L, Leng TD, Yang T, Li J, Xiong ZG. Protein Kinase C Regulates ASIC1a Protein Expression and Channel Function via NF-kB Signaling Pathway. Mol Neurobiol. 2020 Nov; 57(11):4754-4766.
-
Crawford TQ, Jalbert E, Ndhlovu LC, Barbour JD. Concomitant evaluation of PMA+ionomycin-induced kinase phosphorylation and cytokine production in T cell subsets by flow cytometry. Cytometry A. 2014 Mar; 85(3):268-76.
-
Sharma A, Fonseca LL, Rajani C, Yanagida JK, Endo Y, Cline JM, Stone JC, Ji J, Ramos JW, Lorenzo PS. Targeted deletion of RasGRP1 impairs skin tumorigenesis. Carcinogenesis. 2014 May; 35(5):1084-91.
-
Oladipupo S, Hu S, Kovalski J, Yao J, Santeford A, Sohn RE, Shohet R, Maslov K, Wang LV, Arbeit JM. VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting. Proc Natl Acad Sci U S A. 2011 Aug 09; 108(32):13264-9.
-
Thompson S, Pearson AN, Ashley MD, Jessick V, Murphy BM, Gafken P, Henshall DC, Morris KT, Simon RP, Meller R. Identification of a novel Bcl-2-interacting mediator of cell death (Bim) E3 ligase, tripartite motif-containing protein 2 (TRIM2), and its role in rapid ischemic tolerance-induced neuroprotection. J Biol Chem. 2011 Jun 03; 286(22):19331-9.
-
Arakawa R, Bagashev A, Song L, Maurer K, Sullivan KE. Characterization of LRRFIP1. Biochem Cell Biol. 2010 Dec; 88(6):899-906.
-
Yakubu MA, Nsaif RH, Oyekan AO. Regulation of cerebrovascular endothelial peroxisome proliferator activator receptor alpha expression and nitric oxide production by clofibrate. Bratisl Lek Listy. 2010; 111(5):258-64.
-
Smirnova IS, Chang S, Forsthuber TG. Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro. Cell Immunol. 2010; 261(1):29-36.
-
Perez-Torres M, Valle BL, Maihle NJ, Negron-Vega L, Nieves-Alicea R, Cora EM. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Exp Cell Res. 2008 Oct 01; 314(16):2907-18.
-
Awumey EM, Howlett AC, Putney JW, Diz DI, Bukoski RD. Ca(2+) mobilization through dorsal root ganglion Ca(2+)-sensing receptor stably expressed in HEK293 cells. Am J Physiol Cell Physiol. 2007 May; 292(5):C1895-905.